A drug screening reveals minocycline hydrochloride as a therapeutic option to prevent breast cancer cells extravasation across the blood-brain barrier

HIGHLIGHTS

• who: Joana Godinho-Pereira and colleagues from the iMed-Research Institute for Medicines, Faculty of Pharmacy, Universidade de Lisboa, AvProfGama Pinto have published the paper: A Drug Screening Reveals Minocycline Hydrochloride as a Therapeutic Option to Prevent Breast Cancer Cells Extravasation across the Blood-Brain Barrier, in the Journal: Biomedicines 2022, 10, x FOR PEER REVIEW of /2022/
• what: The authors aimed to find able to boost blood-brain barrier (BBB) properties and prevent BC cells (BCCs) extravasation among PI3K HSP90 and EGFR inhibitors and approved drugs. The authors aimed to disclose a pharmacological modulator . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.